Anthrax Vaccine And Antitoxin Combined

The new study, led by Scripps Research scientists was recently published in PLoS Pathogens*. "The new anti-anthrax agent that we developed is an important and potentially critical development for anyone who works with the bacterium or those who might be exposed to it in a bioterrorism attack," Schneemann said. "While other strategies are being pursued to develop improved anthrax vaccines, none of these offer the distinct advantage of combining the function of a vaccine with a potent antitoxin."